# Holobiome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/holobiome

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.holobiome.org
- Latest round: Seed (Jun 22, 2021)
- Investors on record: 3

## About

Based in Massachusetts, US, and co-founded by Philip Strandwitz (CEO), Mike La Fleur (President), and Kim Lewis, Holobiome Inc. operates as a biotechnology research company specializing in solving the complexities of the human gut microbiome. In June 2021, the firm raised venture capital led by investor Corundum Systems Biology, Alexandria Venture Investments, and iSelect.

The company is focused on discovering and developing therapies from the human microbiome. The company translates the science of the human microbiome into probiotics and targeted solutions for nervous system disorders and other major whole-body health problems. Holobiome’s product lineup includes probiotics and specialized solutions derived from human gut microbes. Holobiome aims to provide treatments and contribute to improved health outcomes for individuals worldwide.

## Funding rounds

- Seed, Jun 22, 2021 — Alexandria Venture Investments, iSelect Fund Management, Corundum Systems Biology
- Seed, Apr 9, 2019 — Alexandria Venture Investments

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Seed
- iSelect Fund Management (https://capitalatlas.ai/funds/iselect-fund-management) — Seed
- Corundum Systems Biology (https://capitalatlas.ai/funds/corundum-systems-biology) — Seed